Dr. Annelize Wandelseck
ActiveSummary
Dr. Annelize Wandelseck has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €200,747 and a net result of €93,594. The computed 12-month bankruptcy probability is 0.1% (very low).
History
On 11 August 2023, Dr. Annelize Wandelseck was incorporated as a private limited company by one natural person, with a starting capital of €5,000.12 Annelize Wandelseck has served as director of the company since 2023.2 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Liquidity more than doubledcurrent ratio 8.37
Current ratio from 3.60 to 8.37; short-term debt falls from €37,142 to €26,148.
31-12
Financial
Equity above €200,000equity €200,747 ▲87.3%
A profit in every financial year since 2024 builds equity to €200,747.
28-03
NBB filing
Annual accounts filed
financial year 2024 · micro format
2023
16-08
Gazette deed
IncorporationAppointment: Annelize Wandelseck (director) · Registered office clause · Pre-incorporation commitments7 facts ▸
Gazette deed
Incorporation
Appointment: Annelize Wandelseck (director) · Registered office clause · Pre-incorporation commitments7 facts ▸
- Registered office clause, “3200 Aarschot,Heikenstraat 23” (deed in Dutch)
- Pre-incorporation commitments, “takeover, rechten en verbintenissen uit rechtshandelingen in naam en voor rekening gesteld voor oprichting” (deed in Dutch)
- Director appointment, Annelize Wandelseck (director)
- Incorporation, “Dr.AnnelizeWandelseck” (deed in Dutch)
- Founder, WANDELSECKAnnelize
- Founding capital, €5,000
- Capital
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read